Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

The critique highlights an error in a review about hair loss treatment, stressing the need for accurate information and caution due to poor evidence quality.

Finasteride may improve prostate cancer treatment outcomes.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.